GDTC · Company research
CytoMed Therapeutics Limited Ordinary Shares (GDTC): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
15records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| The chairman bought 29,250 shares in CytoMed Therapeutics (NASDAQ: GDTC) and reported his stake. - Stock Titan | The chairman bought 29,250 shares in CytoMed Therapeutics (NASDAQ: GDTC) and reported his stake. Stock Titan | View source ↗ | Stock Titan | Oct 16, 2026 | neutral | 0 | 0.6 |
| CytoMed Therapeutics (NASDAQ: GDTC) chairman buys shares, reports a 24.92% stake. - Stock Titan | CytoMed Therapeutics (NASDAQ: GDTC) chairman buys shares, reports a 24.92% stake. Stock Titan | View source ↗ | Stock Titan | Oct 13, 2026 | neutral | 0 | 0.6 |
| CytoMed Therapeutics (Nasdaq:GDTC) - Stock Analysis - Simply Wall Street | CytoMed Therapeutics (Nasdaq:GDTC) - Stock Analysis Simply Wall Street | View source ↗ | Simply Wall Street | Oct 12, 2026 | neutral | 0 | 0.6 |
| Nasdaq gives CytoMed until April 5, 2027, to meet its $1 share-price rule. - Stock Titan | Nasdaq gives CytoMed until April 5, 2027, to meet its $1 share-price rule. Stock Titan | View source ↗ | Stock Titan | Oct 9, 2026 | neutral | 0 | 0.6 |
| CytoMed Therapeutics Limited Ordinary Shares (NASDAQ: GDTC) Stock Price, News & Analysis - kalkine.ca | CytoMed Therapeutics Limited Ordinary Shares (NASDAQ: GDTC) Stock Price, News & Analysis kalkine.ca | View source ↗ | kalkine.ca | Aug 25, 2026 | neutral | 0 | 0.6 |
| CytoMed (GDTC) Snapshot: Declines 4.78% to $0.86 on the Day; Price Context: the Current Price Sits Inside the Supplied Technical Range in Latest Trading - Death Cross - https://www.dars.gov.et/ | CytoMed (GDTC) Snapshot: Declines 4.78% to $0.86 on the Day; Price Context: the Current Price Sits Inside the Supplied Technical Range in Latest Trading - Death Cross https://www.dars.gov.et/ | View source ↗ | https://www.dars.gov.et/ | Aug 21, 2026 | neutral | 0 | 0.6 |
| CytoMed Therapeutics' US$1.7m Market Cap Fall Books Insider Losses - Simply Wall Street | CytoMed Therapeutics' US$1.7m Market Cap Fall Books Insider Losses Simply Wall Street | View source ↗ | Simply Wall Street | Jul 24, 2026 | neutral | 0 | 0.6 |
| Insider Purchase: Director at $GDTC Buys 112,000 Shares - Moomoo | Insider Purchase: Director at $GDTC Buys 112,000 Shares Moomoo | View source ↗ | Moomoo | Jun 15, 2026 | neutral | 0 | 0.6 |
| CytoMed Therapeutics (NASDAQ: GDTC) to run first-in-human Malaysia trial of donor-derived γδ T cells - Stock Titan | CytoMed Therapeutics (NASDAQ: GDTC) to run first-in-human Malaysia trial of donor-derived γδ T cells Stock Titan | View source ↗ | Stock Titan | Dec 8, 2025 | neutral | 0 | 0.6 |
| CytoMed Therapeutics (GDTC) Stock Forecast and Price Target 2026 - MarketBeat | CytoMed Therapeutics (GDTC) Stock Forecast and Price Target 2026 MarketBeat | View source ↗ | MarketBeat | May 11, 2024 | neutral | 0 | 0.6 |
| GDTC Stock Price and Chart — NASDAQ:GDTC - TradingView | GDTC Stock Price and Chart — NASDAQ:GDTC TradingView | View source ↗ | TradingView | Jan 23, 2024 | neutral | 0 | 0.6 |
| symbol__ Stock Quote Price and Forecast - CNN | symbol__ Stock Quote Price and Forecast CNN | View source ↗ | CNN | Dec 18, 2023 | neutral | 0 | 0.6 |
| Why Is CytoMed Therapeutics (GDTC) Stock Up 157% Today? - InvestorPlace | Why Is CytoMed Therapeutics (GDTC) Stock Up 157% Today? InvestorPlace | View source ↗ | InvestorPlace | Jul 11, 2023 | neutral | 0 | 0.6 |
| CytoMed Therapeutics Limited (GDTC) Stock Price, News, Quote & History - Yahoo! Finance Canada | CytoMed Therapeutics Limited (GDTC) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Jun 29, 2023 | neutral | 0 | 0.6 |
| CytoMed and MD Anderson partner to use gdTc for cancer treatment - Pharmaceutical Technology | CytoMed and MD Anderson partner to use gdTc for cancer treatment Pharmaceutical Technology | View source ↗ | Pharmaceutical Technology | May 10, 2023 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.